e-learning
resources
Stockholm 2007
Sunday 16.09.2007
New insights into clinical lung transplantation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of the biological effects of atorvastatin in lung transplant recipients
F. Meloni, A. M. Fietta, N. Solari, M. Morosini, E. Pozzi (Pavia, Italy)
Source:
Annual Congress 2007 - New insights into clinical lung transplantation
Session:
New insights into clinical lung transplantation
Session type:
Electronic Poster Discussion
Number:
324
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Meloni, A. M. Fietta, N. Solari, M. Morosini, E. Pozzi (Pavia, Italy). Evaluation of the biological effects of atorvastatin in lung transplant recipients. Eur Respir J 2007; 30: Suppl. 51, 324
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Special issues in elderly people with solitary pulmonary nodule: non intubated thoracic surgery
Lung transplantation
Severe haemoptysis
Related content which might interest you:
The effect of everolimus on lung function and renal status in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
Respiratory and renal functional evolutionary profiles after introduction of everolimus and minimizing doses of calcineurin inhibitors in lung transplant recipients, a descriptive observational study
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015
Impact of antifibrotic drugs in lung transplantation
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019
Airway cellular response to two different immunosuppressive regimens in lung transplant recipients
Source: Eur Respir J 2004; 24: Suppl. 48, 466s
Year: 2004
Microbiological impact of regular colistin use in a population of lung transplant recipients
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012
The influence of different immunosuppressive regimen on non-mnestic cognitive functions in patients after lung transplantation
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014
Pre-habilitation in lung transplant candidates
Source: Short video discussion 2021
Year: 2021
The effects of dyspnoea in lung transplant candidates
Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy
Year: 2017
Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016
Electronic nose for detecting chronic lung allograft dysfunction in lung transplant recipients
Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?
Year: 2021
Lung cancer in a cardiac and renal transplant recipient: potential role of cyclosporine – a case report
Source: Annual Congress 2008 - Various aspects of thoracic oncology
Year: 2008
Tacrolimus versus cyclosporine for lung transplant recipients in Portugal
Source: Virtual Congress 2020 – Clinical management of lung transplant recipients
Year: 2020
CMV management in lung transplant recipients
Source: School Course 2012 - Lung Transplantation
Year: 2012
Evaluation of early conversion to prolonged-release tacrolimus in lung transplantation.
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
Impact of pulmonary hypertension after lung transplantation on functional outcome
Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Year: 2010
Fatigue and functional capacity in kidney transplant recipients before and after transplant.
Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy
Year: 2017
The use of mTOR inhibitors is associated with improved survival in lung transplant recipients
Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Year: 2020
Impact of drug knowledge on drug errors in an outpatient population of lung transplant recipients
Source: Eur Respir J 2007; 30: Suppl. 51, 176s
Year: 2007
Short and mid-term outcomes of lung transplant recipients with COVID-19
Source: Virtual Congress 2021 – Challenging problems in lung transplantation
Year: 2021
Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation
Source: Eur Respir J 2016; 48: 1807-1810
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept